QuidelOrtho (QDEL) Other Non-Current Liabilities (2022 - 2026)
QuidelOrtho (QDEL) reported Other Non-Current Liabilities of $112.4 million for Q1 2026, up 61.03% on a YoY basis from $69.8 million in Q1 2025, and down 32.45% sequentially from $166.4 million in Q4 2025.
QuidelOrtho (QDEL) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
QuidelOrtho (QDEL) has 5 years of Other Non-Current Liabilities data on file, last reported at $112.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 61.03% year-over-year to $112.4 million; the trailing twelve-month figure through Mar 2026 stood at $112.4 million (up 61.03% YoY), and the FY2025 full-year result was $166.4 million, up 200.9% from the prior year.
- Other Non-Current Liabilities declined to $112.4 million in Q1 2026, from $166.4 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $166.4 million in Q4 2025 to a low of $48.5 million in Q1 2022.
- A 5-year average of $92.2 million and a median of $83.8 million in 2023 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities slumped 39.33% in 2024 and surged 200.9% in 2025, its largest moves.
- Tracing QDEL's Other Non-Current Liabilities over 5 years: stood at $86.6 million in 2022, then fell by 3.46% to $83.6 million in 2023, then sank by 33.85% to $55.3 million in 2024, then surged by 200.9% to $166.4 million in 2025, then sank by 32.45% to $112.4 million in 2026.
- Business Quant data shows QDEL's Other Non-Current Liabilities at $112.4 million in Q1 2026, $166.4 million in Q4 2025, and $138.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | QuidelOrtho | 1.13 Bn | 990.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 112.40 Mn |
| Dec 28, 2025 | 166.40 Mn |
| Sep 28, 2025 | 138.70 Mn |
| Jun 29, 2025 | 133.00 Mn |
| Mar 30, 2025 | 69.80 Mn |
| Dec 29, 2024 | 55.30 Mn |
| Sep 29, 2024 | 119.30 Mn |
| Jun 30, 2024 | 70.50 Mn |
| Mar 31, 2024 | 67.40 Mn |
| Dec 31, 2023 | 83.60 Mn |
| Oct 1, 2023 | 65.40 Mn |
| Jul 2, 2023 | 68.50 Mn |
| Apr 2, 2023 | 111.10 Mn |
| Jan 1, 2023 | 83.80 Mn |
| Oct 2, 2022 | 86.60 Mn |
| Jul 3, 2022 | 87.30 Mn |
| Jan 2, 2022 | 48.50 Mn |